Stereotactic body radiation therapy (SBRT) to central lung tumors is associated with normal tissue toxicity. Highly conformal technologies may reduce the risk of complications. This study compares physical dose characteristics and anticipated risks of radiation pneumonitis (RP) among three SBRT modalities: robotic radiosurgery (RR), helical tomotherapy (HT) and volumetric modulated arc therapy (VMAT). Nine patients with central lung tumors 5 cm were compared. RR, HT and VMAT plans were developed per RTOG 0831. Dosimetric comparisons included target coverage, conformity index, heterogeneity index, gradient index, maximal dose at 2 cm from target (D2 cm), and dose-volume parameters for organs at risk (OARs). Efficiency endpoints included total beam-on time and monitor units. RP risk was derived from Lyman-Kutcher-Burman modeling on in-house software. The average GTV and PTV were 11.6 6 7.86 cm 3 and 36.8 6 18.1 cm 3 .
Introduction
Stereotactic body radiotherapy (SBRT) has become a standard treatment option for medically inoperable early stage nonsmall cell lung cancer (NSCLC) patients, with excellent clinical outcomes. Previous studies have reported 5-year local control rates of 90% and overall survival rates comparable to surgical series when tumors receive a biological equivalent dose (BED 10 ) greater than 100 Gy (1) (2) (3) (4) .
Severe toxicities (Grade 4-5) have been observed when treating centrally located lung lesions with a dose of 60 Gy in 3 fractions (5-7). However, successful outcomes have been reported for tumors in this location when increasing the number of fractions or decreasing the dose per fraction (8, 9) . Currently, the Radiation Therapy Oncology Group (RTOG) is conducting a dose escalation study (protocol 0813) to identify safe fractionation schedules for this area (10) . Besides modifications of dose schemes, the implementation of modern delivery systems may improve the therapeutic ratio by means of superior dose distributions. Today, the most advanced SBRT modalities include robotic radiosurgery (Accuray Inc., Sunnyvale, CA), helical tomotherapy (Accuray Inc., Sunnyvale, CA), and volumetric modulated arc therapy (Varian Medical Systems, Palo Alto, CA and Elekta, Stockholm, Sweden) Robotic radiosurgery (RR) combines non-isocentric beam delivery with image guidance and tracking techniques (11) . Image guidance is achieved by registering a pair of orthogonal x-ray images to digitally reconstructed radiographs (DRRs) generated from the planning CT. Fiducial markers or anatomical landmarks are used to guide the image registration process. In addition, the tracking system can enable synchronization of respiratory-induced target motion with radiation delivery, thus allowing elimination of motionrelated tumor volume expansion (12, 13) . Promising clinical outcomes have been reported in patients with peripheral lesions treated with RR (12, (14) (15) (16) (17) (18) , but only limited studies are available for central lesions (8) .
Helical tomotherapy (HT) is a novel image-guided system capable of delivering intensity-modulated radiation therapy treatments (IMRT) by combining a continuously rotating fan beam with synchronous couch movement (19) . Image guidance is achieved by acquiring 3D images of the patient anatomy using the treatment (megavoltage) beam. Megavoltage CT (MVCT) imaging is highly integrated into the system and it is performed as part of every treatment fraction to improve target localization and reduce setup uncertainties (20) (21) (22) . Previous studies have reported on the feasibility and efficacy of using HT for hypofractionated treatments of centrally located early stage NSCLC and lung metastases (23) (24) (25) .
Volumetric-modulated arc therapy (VMAT) is a recently developed radiotherapy optimization technique which enables delivery of IMRT treatments by combining continuously rotating gantry motion with simultaneous variation of dose rate, gantry speed and segment shape (26) . VMAT treatments can be delivered accurately and efficiently in a substantially shorter time frame than standard IMRT treatments (27) . Kilovoltage cone beam computed tomography (CBCT) can be used for image guidance during VMAT treatments and has the potential to provide direct tumor tracking and adaptive radiation therapy solutions in the future (28) (29) (30) . In addition, respiratory-gated VMAT treatments are available for lung tumors, thus reducing the volume of normal lung exposed to radiation (31) .
The goal of this study was to compare the potential advantages of these three modalities for centrally located lung lesions. Dosimetric parameters were compared as well as the risk of developing symptomatic radiation pneumonitis (RP). The risk of RP was calculated using normal tissue complication probability (NTCP) models.
Materials and Methods

Patient Selection and Contouring
Nine patients with centrally located early stage lung tumors were selected according to the entry criteria for RTOG 0813. Tumors were located within 2 cm of the proximal bronchial tree and were 5 cm in size. All patients were treated with RR SBRT between 2009 and 2012. Cases were classified based on the PTV volume and on the proximity of the PTV to the adjacent critical structures. The latter quantity was defined as the volume of overlap between the PTV and any adjacent critical structure.
For each patient, a plan for each modality (RR, VMAT, HT) was created using identical planning scans and contour sets for a prescription dose of 50 Gy in 5 fractions. Thus, a total of 27 plans were generated. All patients had a wholethorax free-breathing CT scan at 1.5 mm slice thickness and a 4DCT scan using a 16-slice CT scanner (Siemens Somatom Sensation). 4DCT image data were sorted into 8 respiratory phases and maximum intensity projection (MIP) images were generated. Tumor targets and critical structures were contoured according to RTOG 0813 guidelines (10) . The gross tumor volume (GTV) was delineated on the free breathing scan with lung window settings, while the internal target volume (ITV) was delineated on the MIP dataset and then checked against scans from each respiratory phase. The planning target volume (PTV) was created by expanding the ITV by a uniform 5 mm margin to compensate for setup error and residual respiratory motion not represented by 4DCT. 
Planning and Beam Configuration
For all treatment modalities, 6 MV photon beams were used. RR and HT have unflattened photon beams, while for VMAT the flattened photon beam was used. RR plans were generated using the Multiplan treatment planning system, version 4.5 (Accuray Inc., Sunnyvale, CA). The nominal dose rate at isocenter was 1000 cGy/MU. Plans were optimized using the iris variable aperture collimator (32) and the sequential optimization method (33) . The Monte Carlo dose calculation algorithm (1% uncertainty) was used for tissue heterogeneity correction (34) .
HT plans were generated using a binary multileaf collimator (MLC) with a 6.25 mm projected leaf width at the isocenter (which is 85 cm away from the photon source). Field widths of 1.05 or 2.5 cm and a pitch of 0.3 were used. The dose rate at isocenter was 870 cGy/min. A modulation factor of 2 was set at the beginning of the optimization process. The collapsed cone superposition-convolution algorithm was used for dose calculation (35) .
VMAT plans were generated using the Eclipse treatment planning system, version 11, with 5 mm multileaf width and Acuros calculation algorithm. The dose rate at isocenter was 600 cGy/min. Combinations of two full arcs were used. The analytical anisotropic algorithm (AAA) dose calculation algorithm was used for tissue heterogeneity corrections (36) .
Plan Evaluation
A dose of 50 Gy in 5 fractions was prescribed. Acceptable treatment planning met all dose specification criteria in RTOG 0813.
• Target coverage: 95% of the PTV is covered by the prescription dose and 99% of PTV is covered by 99% of the prescription dose. • Target dose heterogeneity: prescription isodose line is between 60% and 90%. • High dose spillage: any dose 105% of the prescription dose (hot spot) is mainly located inside the PTV, and hot spots are not located inside any OAR (even if the OAR is part of the PTV). • Low dose spillage: the dose fall-off beyond the PTV is rapid and meets the criteria of RTOG 0813. • Dose to critical structures (spinal cord, esophagus, brachial plexus, heart, trachea, proximal bronchial tree, lung, skin and great vessels): maximum point dose and dose volume limits are within the limits of RTOG 0813.
The following parameters were collected and evaluated: (37) . A value closer to unity represents better target conformity.
Heterogeneity index (HI):
The HI is defined as the ratio of the maximum dose to the prescription dose. A value closer to unity represents higher dose homogeneity and less heterogeneity.
• The gradient index (GI) is defined as the ratio of the volume receiving a given percentage of the prescription dose to the PTV volume. Typically, GI is reported in terms of 50% of prescription dose and is defined as by R 50% . A value closer to unity represents better dose fall-off.
• D2 cm is defined as the maximum dose at 2 cm from PTV in any direction.
6. Dose-volume parameters: The volume of lung receiving 5 Gy, 15 Gy, 20 Gy and 30 Gy (V5, V15, V20, V30) and the mean lung dose (MLD) for whole, ipsilateral, and contralateral lung volumes were recorded. The lung volume was defined as the entire lung volume excluding the GTV. The maximal dose was evaluated for other critical structures. 7. Total monitor unit (MU) requirement and treatment time:
These were based on the expected delivery parameters of the machine at the time of treatment.
Risk of Radiation-induced Pneumonitis
The risk of developing symptomatic radiation pneumonitis (RP) strongly depends on lung dose-volume parameters.
To assess the probability of grade 2 (or higher) RP and to account for the biological effect of high fractional dose, an in-house Matlab program was developed. The differential dose volume histogram (dDVH) of both lungs was re-scaled to the equivalent dose for 2 Gy/fraction using the Linear-Quadratic model (Eq. 1) with α/β 5 3 for normal lung tissue (38) :
Here D i is the dose for bin i of the dDVH, N is the number of fractions, and α/β is the dose where the linear and quadratic component of the survival curve are equal.
Normal tissue complication probability (NTCP) was derived from Lyman-Kutcher-Burman's (LKB) calculation model
D eff is the dose that, if given uniformly to the entire volume, will lead to the same NTCP as the actual nonuniform dose distribution. TD 50 is the effective dose that results in a 50% complication probability, m is a measure of the slope of the sigmoid dose-response curve, and n is the volume effect parameter. Note that this model is based on an effective dose (Eq. 4), similar to the generalized equivalent uniform dose (gEUD), except the exponents are inverted. This assumes that the risk of complication is equivalent for the entire organ uniformly receiving the effective dose as the organ receiving an inhomogeneous dose distribution. The effective dose is calculated from the volume (v i ) and dose (D i ) per bin in the LQED2-adjusted dDVH obtained from Eq. 1.
The accuracy of NTCP prediction is based on the validity of these 3 parameters (TD 50 , m and n for lung tissue). We extensively reviewed these parameters to accurately estimate the risk of pneumonitis. Historically, these parameters for pneumonitis have been established from clinical data pertaining to conventional radiation treatment, normally defined as TD 50 5 24.5, m 5 0.18 and n 5 0.87 (42) . More recent clinical data from SBRT-related studies of pneumonitis show a TD 50 between 19.6-20.8 based on a normal tissue volume calculated from the bilateral lungs (43, 44) , and 22.4-32.4 Gy for the unilateral lung (45, 46) . The value for m was reported to be 0.43-0.45 for the whole lung (43, 44) , and 0.67 for the unilateral lung (45) . The volume effect parameter, n, has been estimated between 0.87-0.93 (44) .
We calculated the NTCP for bilateral and unilateral volumes separately. For the NTCP prediction using the bilateral lung volumes, we used TD 50 5 20, n 5 0.87 and m 5 0.4. For the unilateral lung, we used m 5 0.67 and n 5 0.87. However, there is a wide range in TD 50 estimates for the unilateral lung. Based on the available estimates, we separately created best (TD 50 5 32.4), average (TD 50 5 27.4) , and worst (TD 50 5 22.4) case scenarios to calculate the NTCP. NTCP curves were created by plotting the probability of RP as a function of mean effective lung dose.
Statistical Analysis
All dosimetric parameters and toxicity probabilities were summarized by the mean and standard deviation. The percent of NTCP was plotted against the mean effective lung dose using different settings of lung volume parameters for each technique (RR, HT and VMAT). To determine whether changes in the dosimetric parameters and NTCP were significantly different among the modalities, a 1-way analysis of variance method for repeated measures was used. When the overall test indicated a statistical difference among the mean values, defined as a probability (p value) less than 0.05, the post hoc Newman-Keuls test was used to identify which approaches differed from each other. There were no adjustments for multiple comparisons.
Results
The median age of patients was 60 years old (range for which the range of overlapping volume was 0.4-19.7 cm 3 (0.1, 0.2, 1.3 and 29% of PTV, respectively). Over half (56%) of the patients had tumors located in the posterior thorax (behind the posterior border of the heart), 33% were in the middle thorax (between the anterior and posterior border of the heart), and 11% were in the anterior thorax. Patient and tumor characteristics are shown in Table I .
For all plans, the dose constraints of RTOG 0813 were achieved, except for one patient whose PTV was 67 cm 3 with the largest area of overlap on the proximal airway and great vessels (19.7 cm 3 ) ( Figure 1C ). For this patient, RR and VMAT failed to limit the 105% hotspot in the region of overlap. The maximal dose to the great vessels for this case was 53.2, 52.5 and 53.8 Gy in RR, HT and VMAT, respectively. RR also failed to limit the ratio of R 50% to be less than 4.8 for this case. R 50% was 5.8, 4.7 and 4.4 in RR, HT and VMAT.
Comparison of Target Dose Distribution
All three techniques resulted in similar target coverage and dose conformity as shown in Table II . RR had a significantly greater inhomogeneity than both of HT and VMAT (p 5 0.0002 for both comparisons). Regarding low dose spillage and fall-off, RR and VMAT had a significantly better gradient index (R 50% ) than HT (p 5 0.002 and 0.04). RR also had a significantly lower D2 cm compared to HT and VMAT (p 5 0.048 and 0.01). However, delivery efficiency was superior for VMAT, HT and RR (p 5 0.0002 for all pairwise comparisons). VMAT reduced delivery time by 55% compared to HT and 91% compared to RR. VMAT reduced MU by 71% compared to HT and 80% compared to RR.
Comparison of Other Organs at Risk
All plans except one achieved the RTOG 0813 dose constraints for critical organs. As described above, in one case, RR and VMAT failed to limit the 105% hotspot within the PTV overlapping on the great vessels. RR, HT and VMAT plans resulted in similar doses to the proximal airway, heart, esophagus and spinal cord. Overall, RR plans delivered significantly lower maximal doses to the great vessel, compared to VMAT (p 5 0.04). However, RR plans delivered significantly higher maximal dose to the brachial plexus, compared to both HT (p 5 0.0003) and VMAT (p 5 0.0002) as shown in Table III .
Comparison of Normal Lung Dose
For the whole lung, RR and VMAT had a significantly lower V5, V15 and V20 compared to HT as shown in Table IV . VMAT had a significant lower D1000 and D1500 compared to RR and HT (p 5 0.005 and p 5 0.006 for D1000, p 5 0.005 and p 5 0.02 for D1500). In addition, the lowest MLD was obtained in VMAT as compared to RR and HT (VMAT vs. RR p 5 0.005, VMAT vs. HT p 5 0.0002, RR vs. VMAT p 5 0.02).
For the contralateral lung, RR had significantly better contralateral lung sparing compared to HT and VMAT as shown by lower V5 (p 5 0.0006 and p 5 0.0004) and lower contralateral MLD (p 5 0.0002 and p 5 0.0008). 
Comparison of Probability of Symptomatic Radiation Pneumonitis (NTCP)
The risk of symptomatic RP was estimated using the parameters for a normal tissue volume of the whole lung (TD 50 5 20, m 5 0.44, n 5 0.87). The NTCP results for each plan are shown in Table V . RR (p 5 0.04) and VMAT (p 5 0.02) plans resulted in a significantly lower risk of symptomatic pneumonitis compared to HT.
The risk of symptomatic RP was also predicted using unilateral lung volume parameters. We calculated unilateral lung NTCP for three scenarios labeled as best (TD 50 5 32.4), average (TD 50 5 27.4) , and worst (TD 50 5 22.4) , using m 5 0.67 and n 5 0.87 as shown in Table VI and Figure 2 . When using ipsilateral lung parameters, RR (p 5 0.004) and VMAT (p 5 0.0008) had a significantly lower risk of RP compared to HT in all scenarios, as shown in Table VI . For contralateral lung parameters, RR plans had a significantly lower risk of RP compared to both HT (p 5 0.0002) and VMAT (p 5 0.0003) in all scenarios. Interestingly, for all scenarios (best, average, worst), the risk of pneumonitis (NTCP) calculated from whole lung parameters was more consistent with the NTCP values estimated from contralateral lung parameters rather than ipsilateral lung parameters (Table VI) . NTCP risk is about 2-3 times higher using only ipsilateral lung parameters. The contralateral or whole lung volume may be more useful in predicting RP risk, particularly for arc-based radiotherapy such as HT and VMAT. Further studies are needed to validate this hypothesis.
Discussion
Due to the proximity of adjacent critical structures, sophisticated radiotherapy techniques are advantageous when treating centrally located lung tumors. In this study, we present the first direct comparison among three of these modalities: RR, HT and VMAT. The physical characteristics of the dose distributions, as well as predictive toxicity models, were used to guide the comparison. All plans were developed according to the specifications of RTOG 0813, a current protocol designed to identify safe treatment of centrally located lung lesions with hypofractionated dose regimens.
Dosimetrically, all three modalities achieved similar target coverage and conformity. While RR plans resulted in better dose fall off at the edge of the target, VMAT and HT plans provided higher dose homogeneity and a significant reduction in treatment time and monitor units. However, these results were obtained using conventional full arc techniques for HT and VMAT planning. It is possible that the addition of blocking parameters for HT planning or multiple partial arcs for VMAT planning would result in sharper dose gradients at the expense of delivery efficiency. In terms of normal structures, RR, HT and VMAT achieved similar doses to proximal airway, heart, esophagus and spinal cord. RR plans provided a lower maximal dose to the great vessels, compared to VMAT and HT, but a higher dose to the brachial plexus.
We selected patients with a variety of tumor locations, dimensions, and proximity to critical structures. To quantify the degree of "proximity" to OARs, we calculated the volume of overlap between the PTV and the adjacent critical structures. One patient presented with a particularly large overlapping volume involving both great vessels and proximal airways (19.7 cm 3 , equal to 29% of the PTV volume). For this patient, it was necessary to increase the dose homogeneity within the target (the dose was prescribed to the 81% isodose line), in order to push any dose 105% of the prescription dose away from OARs in the overlapping area. We observed that in this situation, the RR performance was degraded not only in term of high dose conformity (as indicated by a CN 5 0.79), but also in terms of low dose fall-off (as indicated by D2 cm 5 32.9 and R 50% 5 5.8). On the other hand, HT and VMAT maintained these properties, while limiting hot spots in large overlap regions (for comparison, CN 5 0.9 and 0.86, D2 cm 5 27.3 and 31.6, and R 50% 5 4.7 and 4.4, for HT and VMAT). This observation seems to suggest that RR performs best when the dose homogeneity within the target is not constrained, whereas HT and VMAT can achieve good plan quality despite the level of dose homogeneity within the target.
Since all modalities achieve similar target coverage and dose conformity, we propose that the relative benefits of the techniques can be compared based on sparing of nearby critical structures and reduced risks of toxicity. Our results suggest that PTV size and degree of PTV overlap with central structures (Figure 3 ) can be used to categorize patients. For patients with no or small degree of overlap (10% of the PTV volume), regardless of PTV size, RR provided the best dose fall off and lowest lung dose. For patients with a large amount of overlap (10% of PTV), VMAT or HT achieved good plan quality, while limiting hot spots on critical structures included within the treatment volume. However, for patients with large PTV volumes, VMAT resulted in a potentially lower lung dose and lower risk of pneumonitis as well as decreased treatment time. These results were obtained when using standard RTOG criteria to guide the planning objectives. It is possible that adding additional planning objectives focused on limiting normal lung dose might alter the lung doses and risk of pneumonitis achieved by each planning technique. superior protection for OARs. However, HT plans resulted in larger volumes of lung receiving low levels of radiation, a tendency that was also found in our study.
Zhang et al. (49) compared plans generated with non-coplanar 3D, coplanar and non-coplanar VMAT, and flattening filterfree VMAT (FFF-VMAT) for fifteen lung cancer patients. They concluded that VMAT plans not only shortened the delivery time but also improved the plan quality in terms of dose conformity to the target, dose fall-off in normal tissues and median dose to normal lung.
Holt et al. (27) compared coplanar VMAT with coplanar and non-coplanar IMRT for 27 early stage lung cancer patients with peripheral lesions eligible for SBRT. They concluded that coplanar VMAT and non-coplanar IMRT achieved similar plan quality, which was slightly better than coplanar IMRT. However, VMAT significantly reduced treatment times, improving patient comfort.
Another major consideration in comparing different treatment modalities for lung SBRT is the technology-specific capability for online target localization. While image guidance is highly integrated in all three modalities, a unique characteristic of the RR system is dynamic tumor tracking (12, 13) . In this study, the same contours were used for planning all modalities, since our primary goal was to directly compare physical characteristics of the dose distribution. However, for patients treated with dynamic tracking, a target volume without ITV expansion can be used, possibly further reducing the risk of radiation-induced complications (50, 51) .
One potential limitation to our study may be the use of the linear-quadratic (LQ) model to estimate RP risk. Park et al. (52) first proposed a better fit of the universal survival curve (USC) model compared to LQ by evaluating the cell survival curve from twelve NSCLC cell lines. However, while the USC might be reasonable to predict tumor control probability (TCP), its application to normal tissue complication probability (NTCP) remains unclear. Borst et al. (43) advocate using the LQ model for pneumonitis prediction, due to the potential susceptibility of biological variables in the USC such as α, β, D o , and D q to unpredicted variations in heterogeneous cancer tissue. We believe that the LQ model has sufficient practicality for plan comparison, although further study is needed to evaluate the validity of the LQ and USC models in toxicity prediction.
The estimated symptomatic pneumonitis risk is 2-30% in published SBRT studies (44, 45, (53) (54) (55) (56) (57) (58) (59) . One possible reason for this variability is that some studies have considered the lung as a whole organ and did not distinguish between the ipsilateral and contralateral lung. Two studies did not use whole lung volumes. Guckenberger et al. reported that grade 2 pneumonitis correlated with the mean lung dose to the ipsilateral lung volume (45) . Ong et al. showed that contralateral V5 significantly correlated to grade 2-3 pneumonitis (55) . In our study, the risk of symptomatic pneumonitis was less than 10% when using whole lung and contralateral lung volume parameters, but the risk was increased to 20-30% when using ipsilateral lung volume parameters. In the future, studies should report their findings with a careful annotation of the risk parameters being employed, given that large differences can result depending on the method of calculation.
Conclusion
In this study, three SBRT techniques (RR, HT and VMAT) for treating central lung lesions were investigated in terms of their dosimetric characteristics, delivery efficiency, and probability of radiation-induced symptomatic pneumonitis. All techniques were able to provide clinically acceptable plans following the guidelines provided by RTOG 0813. Target coverage and dose conformity were found to be very similar across modalities. Robotic radiosurgery and VMAT resulted in a superior low dose gradient and lower maximal dose to the great vessels. HT and VMAT resulted in more efficient treatment delivery and in a higher level of target dose homogeneity. The estimated risk of RP for each of the three modalities predicted that using whole lung volume was less than 10%, similar to the risk found using contralateral lung volume. However, RP risk was 2-3 times higher when calculated using ipsilateral lung volumes. Using whole or ipsilateral lung volumes, RR and VMAT had a lower risk of RP than HT, while for contralateral lung volumes, RR had the lowest risk of RP. Thus, RR produced a lower RP risk for a scenario of small PTV-OAR overlap and small PTV. The greater homogeneity produced by HT and VMAT may be desirable for scenarios of large PTV-OAR overlap. VMAT probably yields the lowest RP risk for a large PTV. Understanding subtle differences in the capabilities of these technologies may assist centers where multiple choices of modality are available. These investigations provide a basis for further investigations of the modeling and normal lung parameters to be used in risk predictions related to SBRT. 
